首页> 外文期刊>Russian Open Medical Journal >Posthemorrhagic hydrocephalus with decompensation of cerebrospinal fluid dynamics in newborns: new in treatment tactics
【24h】

Posthemorrhagic hydrocephalus with decompensation of cerebrospinal fluid dynamics in newborns: new in treatment tactics

机译:发育性脑积水与新生儿中脑脊液动力学的反作一定:新生儿策略

获取原文
           

摘要

Background ― Posthemorrhagic hydrocephalus in newborns with occlusion of cerebrospinal fluid leads to decompensation of cerebrospinal fluid dynamics. There is no single method that meets all the criteria for the effectiveness and safety of treatment. The study goal was to investigate the use of coronary translambdoid subarachnoid ventriculostomy (CTSV) and ventricular subarachnoid stenting (VSS) in the treatment of neonatal hydrocephalus. Material and Methods ― The analysis of the posthemorrhagic hydrocephalus treatment in 327 newborns for the period of 2000-2018 in Crimea. Two groups have been identified. In the Group 1, 184 children underwent standard treatment according to the ‘LVV protocol’ with lumbar and ventricular punctures with 20-22G needles, while with progression of hydrocephalus, with ventriculosubgaleal drainage and ventriculoperitoneal shunt. In 143 children with occlusion and ventricular block, the treatment complex included CTSV – RF Patent No. 2715535, and ventricular drainage by the ventricular subarachnoid stenting (VSS) – RF Patent No. 2721455. Results ― An increase in the treatment radicality under CTSV is achieved through the use of the cerebral needles of a larger diameter (14G) and puncture access zones, elimination of occlusion, while under VSS, restoration of intracranial circulation and absorption of cerebrospinal fluid is ensured by prolonged sanitation with a saline solution of cerebrospinal fluid spaces. A positive outcome with compensation for hydrocephalus was achieved in 75.4% of cases versus 28.2% under the conventional protocol (p0.001). In other cases, the imbalance of production and absorption of cerebrospinal fluid remained, which required the integration of the VSS with the peritoneal segment of the shunt, without further replacement and reinstallation of the system. Conclusion ― Our results allow us to consider the effectiveness of CTSV and VSS inclusion in the contemporary algorithm for the treatment of decompensated posthemorrhagic hydrocephalus in newborns.
机译:背景 - 新生儿脑膜瘤患者脑脊液闭塞导致脑脊液动力学的反作一决。没有单一方法符合治疗效果和安全性的所有标准。该研究目标是探讨冠状动脉αrambdoid蛛网膜下腔脑室(CTSV)和心室蛛网膜下腔支架(VSS)治疗新生儿脑积水的使用。材料与方法 - 2000 - 2018年327次新生儿治疗对克里米亚时期的脑力脑药治疗分析。已经确定了两组。在第1,184族,儿童接受标准治疗的“LVV议定书”,腰部和室性穿刺,患有20-22G针,同时患有脑积水的进展,具有脑室毛细血管引流和脑室肌瘤分流。在143例闭塞和心室嵌段的儿童中,该治疗复合物包括CTSV - RF专利No.2715535,心室蛛网膜下腔支架(VSS) - 射频专利No.2721455的心室引流。结果 - CTSV下的治疗自由度增加通过使用较大直径(14g)和穿刺接入区的脑针来实现,消除闭塞,而在VSS下,通过延长静卫生液的脑脊液空间的盐水溶液,确保颅内循环的恢复和脑脊液的吸收。在常规方案下,75.4%的病例与28.2%的病例达到脑积水的阳性结果(P <0.001)。在其他情况下,脑脊液的产生和吸收的不平衡仍然存在,这需要与分流器的腹膜段整合,而无需进一步更换和重新安装该系统。结论 - 我们的结果允许我们考虑CTSV和VSS纳入当代算法,以治疗新生儿的失代偿性假鼠脑药。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号